<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Phosphatidylinositol (PI) decreases Psoriasis — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Phosphatidylinositol (PI)</strong>
  <span class="pred">&mdash;decreases&rarr;</span>
  <strong>Psoriasis</strong>
</div>
<div class="entity-id">HMDB:HMDB0004097 &nbsp;&middot;&nbsp; MESH:D011565</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 62.00<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.0 (Physical) &times; log&#8322;(1+1) = 10.00<br>Incoming citations: 7 &rarr; score 62.00</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1093/gigascience/gix087">10.1093/gigascience/gix087</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS408">MTBLS408</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 7 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:20px"></span><span>1</span><span class="cite-subtotal">&middot; +10.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Glycerophospholipid metabolism — correlates_with → Psoriasis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/7959461355e976a2.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:100px"></span><span>5</span><span class="cite-subtotal">&middot; +40.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophosphatidic acid (LPA) — increases → Psoriasis</span><span class="cite-claim-weight">+8.00</span><a href="../claim/ecd2aa839b76d2f2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — increases → Psoriasis</span><span class="cite-claim-weight">+8.00</span><a href="../claim/8ae80e0e48ab27cf.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Phosphatidic acid (PA) — increases → Psoriasis</span><span class="cite-claim-weight">+8.00</span><a href="../claim/f9ae007136ec723f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophosphatidic acid (LPA) — is_biomarker_for → Psoriasis</span><span class="cite-claim-weight">+8.00</span><a href="../claim/567eaedbddd0c1c8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — is_biomarker_for → Psoriasis</span><span class="cite-claim-weight">+8.00</span><a href="../claim/00268f974bb50858.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:20px"></span><span>1</span><span class="cite-subtotal">&middot; +12.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Phosphatidylcholine (PC) — decreases → Psoriasis</span><span class="cite-claim-weight">+12.00</span><a href="../claim/e5e90139bb48f28f.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>8f33fc24536d24e4</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0004097">HMDB:HMDB0004097</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D011565">MESH:D011565</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
